0
Inquiry Basket
Quote

Recombinant HIV-2 gp32 Antigen, beta-galactosidase-tagged, HRP-Labled

Cat# : HIV-296

Product Datasheets COA :
Catalog# Product Name Availability Size Price Qty
HIV-296 Recombinant HIV-2 gp32 Antigen, beta-galactosidase-tagged, HRP-Labled April 27, 2024 1 vial $998.00
Add to Cart Online Order Request a Bulk Order
Cat#:  HIV-296
Product Name:  Recombinant HIV-2 gp32 Antigen, beta-galactosidase-tagged, HRP-Labled
Description:  HIV-2 gp32 HRP Labeled recombinant-contains the full-length sequence of HIV-2 envelope immunodominant regions gp32 having a Mw of 32 kDa and fused to a beta-galactosidase at N-terminus.
Species:  HIV-2
Molecular Weight:  32 kDa
Source:  Escherichia Coli.
Introduction:  HIV-1 and HIV-2 appear to package their RNA differently. HIV-1 binds to any appropriate RNA whereas HIV-2 preferentially binds to mRNA which creates the Gag protein itself. This means that HIV-1 is better able to mutate. HIV-2 is transmitted in the same ways as HIV-1: Through exposure to bodily fluids such as blood, semen, tears and vaginal fluids.Immunodeficiency develops more slowly with HIV-2.HIV-2 is less infectious in the early stages of the virus than with HIV-1.The infectiousness of HIV-2 increases as the virus progresses.Major differences include reduced pathogenicity of HIV-2 relative to HIV-1, enhanced immune control of HIV-2 infection and often some degree of CD4-independence. Despite considerable sequence and phenotypic differences between HIV-1 and 2 envelopes, structurally they are quite similar. Both membrane-anchored proteins eventually form the 6-helix bundles from the N-terminal and C-terminal regions of the ectodomain, which is common to many viral and cellular fusion proteins and which seems to drive fusion.HIV-1 gp41 helical regions can form more stable 6-helix bundles than HIV-2 gp41 helical regions however HIV-2 fusion occurs at a lower threshold temperature (25°C), does not require Ca2+ in the medium, is insensitive to treatment of target cells with cytochalasin B, and is not affected by target membrane glycosphingolipid composition.
Purity:  Greater than 95.0% as determined by SDS-PAGE.
Formulation:  0.01M Na2CO3, 10mM EDTA, 14mM beta-ME and 0.02% Sarcosyl.
Stability:  HIV-2 gp-32 although stable at room temperature for 3 weeks, should be stored at 4°C.
Physical Appearance:  Sterile filtered colorless clear solution.
For research use only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.

Online Inquiry

  • Size: 100ug 500ug 1mg 5mg 10mg 100mg 500mg 1g
  • Conjugation: None R-PE APC Biotin FITC Alexa Flour Others
CONTACT US

For more information on how our products could help advance your project, please contact us.

Contact Us

ENTER YOUR EMAIL HERE TO SUBSCRIBE.

Copyright © 2024 Creative BioMart. All Rights Reserved.